These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 30717056)

  • 1. Moyamoya syndrome and PHACE syndrome: clinical and radiographic characterization of the intracranial arteriopathy and response to surgical revascularization.
    Jernigan S; Storey A; Hammer C; Riordan C; Orbach DB; Scott RM; Smith E
    J Neurosurg Pediatr; 2019 Apr; 23(4):493-497. PubMed ID: 30717056
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bilateral pial synangiosis in a child with PHACE syndrome.
    Jack AS; Chow MM; Fiorillo L; Chibuk T; Yager JY; Mehta V
    J Neurosurg Pediatr; 2016 Jan; 17(1):70-5. PubMed ID: 26405843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Moyamoya Vasculopathy in PHACE Syndrome: Six New Cases and Review of the Literature.
    Tortora D; Severino M; Accogli A; Martinetti C; Vercellino N; Capra V; Rossi A; Pavanello M
    World Neurosurg; 2017 Dec; 108():291-302. PubMed ID: 28887276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of Moyamoya disease in the adult population with pial synangiosis.
    Lin N; Aronson JP; Manjila S; Smith ER; Scott RM
    J Neurosurg; 2014 Mar; 120(3):612-7. PubMed ID: 24405066
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pial synangiosis in patients with moyamoya syndrome and sickle cell anemia: perioperative management and surgical outcome.
    Smith ER; McClain CD; Heeney M; Scott RM
    Neurosurg Focus; 2009 Apr; 26(4):E10. PubMed ID: 19335126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term outcome in children with moyamoya syndrome after cranial revascularization by pial synangiosis.
    Scott RM; Smith JL; Robertson RL; Madsen JR; Soriano SG; Rockoff MA
    J Neurosurg; 2004 Feb; 100(2 Suppl Pediatrics):142-9. PubMed ID: 14758941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Moyamoya syndrome associated with Down syndrome: outcome after surgical revascularization.
    Jea A; Smith ER; Robertson R; Scott RM
    Pediatrics; 2005 Nov; 116(5):e694-701. PubMed ID: 16263984
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Surgical Revascularization for Children with Moyamoya Disease: A New Modification to the Pial Synangiosis.
    Chen C; Wang H; Hou B; Luo L; Guo Y
    World Neurosurg; 2018 Feb; 110():e203-e211. PubMed ID: 29102749
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of PHACES syndrome: Risk of stroke and its prevention from a neurosurgical perspective.
    Habib M; Manilha R; Khan N
    Eur J Paediatr Neurol; 2020 May; 26():39-45. PubMed ID: 32276757
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Moyamoya syndrome associated with neurofibromatosis Type 1: perioperative and long-term outcome after surgical revascularization.
    Koss M; Scott RM; Irons MB; Smith ER; Ullrich NJ
    J Neurosurg Pediatr; 2013 Apr; 11(4):417-25. PubMed ID: 23373626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pial synangiosis in patients with moyamoya younger than 2 years of age.
    Jackson EM; Lin N; Manjila S; Scott RM; Smith ER
    J Neurosurg Pediatr; 2014 Apr; 13(4):420-5. PubMed ID: 24527861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Posterior cerebral territory ischemia in pediatric moyamoya: Surgical techniques and long-term clinical and radiographic outcomes.
    Montaser A; Kappel AD; Driscoll J; Day E; Karsten M; See AP; Orbach DB; Smith ER
    Childs Nerv Syst; 2024 Mar; 40(3):791-800. PubMed ID: 37955716
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Down syndrome and moyamoya: clinical presentation and surgical management.
    See AP; Ropper AE; Underberg DL; Robertson RL; Scott RM; Smith ER
    J Neurosurg Pediatr; 2015 Jul; 16(1):58-63. PubMed ID: 25837890
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Preoperative transdural collateral vessels in moyamoya as radiographic biomarkers of disease.
    Storey A; Michael Scott R; Robertson R; Smith E
    J Neurosurg Pediatr; 2017 Mar; 19(3):289-295. PubMed ID: 27935469
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progression of disease in unilateral moyamoya syndrome.
    Smith ER; Scott RM
    Neurosurg Focus; 2008; 24(2):E17. PubMed ID: 18275294
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative contributions of the middle meningeal artery and superficial temporal artery in revascularization surgery for moyamoya syndrome in children: the results of superselective angiography.
    King JA; Armstrong D; Vachhrajani S; Dirks PB
    J Neurosurg Pediatr; 2010 Feb; 5(2):184-9. PubMed ID: 20121368
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Moyamoya angiopathy in PHACE syndrome not associated with RNF213 variants.
    Hadisurya J; Guey S; Grangeon L; Wieczorek D; Corpechot M; Schwitalla JC; Kraemer M
    Childs Nerv Syst; 2019 Jul; 35(7):1231-1237. PubMed ID: 31037424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pial synangiosis for moyamoya disease. The Bordeaux experience].
    Jecko V; Penchet G; Champeaux C
    Neurochirurgie; 2016 Aug; 62(4):190-6. PubMed ID: 27113323
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Indirect revascularization with the dural inversion technique for pediatric moyamoya disease: 20-year experience.
    Gadgil N; Lam S; Pyarali M; Paldino M; Pan IW; Dauser RC
    J Neurosurg Pediatr; 2018 Nov; 22(5):541-549. PubMed ID: 30117790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgical treatment of moyamoya syndrome in patients with sickle cell anemia: outcome following encephaloduroarteriosynangiosis.
    Hankinson TC; Bohman LE; Heyer G; Licursi M; Ghatan S; Feldstein NA; Anderson RC
    J Neurosurg Pediatr; 2008 Mar; 1(3):211-6. PubMed ID: 18352765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.